Straits Times Index
3,293.13 +20.41 (+0.62%) S&P 500
5,070.55 +59.95 (+1.20%) Dow
38,503.69 +263.71 (+0.69%) Nasdaq
15,696.64 +245.33 (+1.59%) Bitcoin USD
66,430.95 +250.30 (+0.38%) CMC Crypto 200
1,431.45 +7.35 (+0.52%)
Agilent Technologies, Inc. (A)
After hours:
| Previous close | 133.91 |
| Open | 137.98 |
| Bid | 69.00 x 1000 |
| Ask | 168.80 x 900 |
| Day's range | 136.03 - 139.65 |
| 52-week range | 96.80 - 151.58 |
| Volume | |
| Avg. volume | 1,604,009 |
| Market cap | 40.793B |
| Beta (5Y monthly) | 1.12 |
| PE ratio (TTM) | 33.30 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.94 (0.68%) |
| Ex-dividend date | 01 Apr 2024 |
| 1y target est | N/A |
- CNW Group
Reitmans (Canada) Limited Reports Fiscal 2024 and Fourth Quarter Fiscal 2024 Financial Results
Reitmans (Canada) Limited ("RCL" or the "Company") (TSXV: RET) (TSXV: RET-A), Canada's leading specialty apparel retailer, announces its results for the fourth quarter of fiscal 2024. Unless otherwise indicated, all comparisons of results for the 14 weeks ended February 3, 2024 ("fourth quarter of 2024") are against results for the 13 weeks ended January 28, 2023 ("fourth quarter of 2023") and all comparisons of results for the 53 weeks ended February 3, 2024 ("fiscal 2024") are against the resu
- Business Wire
Agilent Receives Scientists' Choice Awards for Sustainability
SANTA CLARA, Calif., April 16, 2024--Agilent Technologies Inc. (NYSE: A) announces that it is the recipient of two 2023 Sustainability Scientists’ Choice awards — Sustainable Supplier of the Year and Sustainable Product of the Year. These awards recognize Agilent as a leader in the area of sustainability.
- Business Wire
Agilent Receives European IVDR Class C Certification for GenetiSure Dx Postnatal Assay
SANTA CLARA, Calif., April 15, 2024--Agilent Technologies Inc. (NYSE: A) today announced that its GenetiSure Dx Postnatal Assay has received European IVDR Class C Certification. This certification demonstrates that the assay meets the higher standards established by IVDR. It ensures the continued availability of this trusted qualitative assay to clinical geneticists and other healthcare professionals throughout the EU.
